NitroMist NovaDel Pharma - Treatment for Angina Pectoris
NitroMist is an oral spray formulation of nitroglycerin indicated for acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.Posted: November 2006
Related articles
- FDA Accepts Submission for NitroMist as Complete Response - May 26, 2006
- NovaDel Pharma Receives Approvable Letter from the FDA for NitroMist - nitroglycerin lingual aerosol - June 2, 2005
- NovaDel NDA for Nitroglycerin Lingual Spray is Accepted for Review by FDA - September 29, 2004
- NovaDel Pharma files for US FDA approval of Nitroglycerin Lingual Spray, its first product - June 21, 2004
NitroMist (nitroglycerin) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
